Large-scale testing (Phase 3)Study completedNCT00032786What this trial is testingSafety and Efficacy of Natalizumab in the Treatment of Crohn's DiseaseWho this might be right forCrohn's Disease Biogen
Not applicableLooking for participantsNCT05849012What this trial is testingA Pilot Study Examining Low Sulfur Diet as Treatment for Persistent Symptoms in Quiescent Crohn's DiseaseWho this might be right forCrohn's Disease in Remission University of Michigan 20
Not applicableStudy completedNCT03774485What this trial is testingMyoelectric GutPrint-Crohn's DiseaseWho this might be right forCrohn Disease Stanford University 136
Not applicableStudy completedNCT02843100What this trial is testingDiet for Induction and Maintenance of Remission and Re-biosis in Crohn's DiseaseWho this might be right forCrohn's Disease Prof. Arie Levine 63
Not applicableUnknownNCT01823042What this trial is testingThe Efficacy of Enteral Nutrition in Fill of the Treatment Blank Period of the Postoperative Maintain Remission Medication for Crohn's Disease (CD)Who this might be right forCrohn's Disease Jinling Hospital, China 100
Post-approval studies (Phase 4)Study completedNCT02852694What this trial is testingReduce Risk for Crohn's Disease PatientsWho this might be right forCrohn's Disease PIBD-Net 192
Not applicableUnknownNCT04653259What this trial is testingDigital Nutrition Therapy for Patients With IBDWho this might be right forCrohn DiseaseUlcerative Colitis University of Calgary 44
Not applicableStudy completedNCT04239248What this trial is testing"Tasty&Healthy" Dietary Approach for Crohn's DiseaseWho this might be right forCrohn Disease Shaare Zedek Medical Center 129
Post-approval studies (Phase 4)UnknownNCT02452151What this trial is testing"Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial"Who this might be right forColitis, UlcerativeCrohn's Disease Onze Lieve Vrouwe Gasthuis 300
Testing effectiveness (Phase 2)Study completedNCT00528073What this trial is testingPlacebo Controlled Study of 3 Doses of Rifaximin-EIR Tablet to Treat Moderate, Active Crohn's DiseaseWho this might be right forCrohn's Disease Alfasigma S.p.A. 410
Testing effectiveness (Phase 2)UnknownNCT00731172What this trial is testingA Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's DiseaseWho this might be right forCrohns Disease Tel-Aviv Sourasky Medical Center 50
Not applicableStudy completedNCT02231814What this trial is testingThe Crohn's Disease Exclusion Diet With Partial Enteral Nutrition or Alone in Adult Patients With Crohn's DiseaseWho this might be right forCrohn's Disease Prof. Arie Levine 40
Post-approval studies (Phase 4)Study completedNCT02010762What this trial is testingThe Effect of Vitamin D3 to Maintain Surgical Remission in Postoperative Crohn's DiseaseWho this might be right forCrohn's Disease Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 142
Testing effectiveness (Phase 2)Study completedNCT01809275What this trial is testingSafety and Treatment Effect of QBECO in Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's DiseaseInflammatory Bowel Disease Qu Biologics Inc. 68
Post-approval studies (Phase 4)Study completedNCT02177071What this trial is testingA proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination TherapyWho this might be right forCrohn's Disease Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives 211
Post-approval studies (Phase 4)WithdrawnNCT02820493What this trial is testingEffectiveness of Vedolizumab in CD Patients Naïve to Anti-TNFWho this might be right forCrohn Disease Universita degli Studi di Genova
Large-scale testing (Phase 3)UnknownNCT00132184What this trial is testingVitamin D Treatment for Crohn´s DiseaseWho this might be right forCrohns Disease University of Aarhus 110
Large-scale testing (Phase 3)Study completedNCT02914561What this trial is testingFilgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn's Disease Lakefront Biotherapeutics NV 1,372
Post-approval studies (Phase 4)Study completedNCT02453776What this trial is testingPrecision Dosing of Infliximab Versus Conventional Dosing of InfliximabWho this might be right forInflammatory Bowel Disease Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 80
Large-scale testing (Phase 3)Ended earlyNCT00295165What this trial is testingEfficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's DiseaseWho this might be right forCrohn Disease Genzyme, a Sanofi Company 33